16Jun 2018

OXIDATIVE STRESS STATUS IN PATIENTS WITH TYPE2 DIABETES MELLITUS.

  • Sudan Atomic Energy Commission.
  • Department of Biochemistry, Khartoum.
  • Khartoum University, Faculty of Medicine.
  • National Research Center in Cairo, Egypt.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Oxidative stress due to chronic hyperglycemia has been implicated in the pathogenesis of type 2 diabetes and its complications. Objectives: To estimate the levels of antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and lipid peroxidation marker i.e. malondialdehyde (MDA) in type 2 DM patients with and without complications i.e., neuropathy, nephropathy and cardiovascular diseases compared to normal subjects. To access the association between oxidative stress and diabetes mellitus and development of its complication. Materials and methods: Plasma levels of SOD, CAT and MDA were estimated in 50 Control and 140 diabetic patients divided into: DWC group consisted of diabetic patients without complications, CAD group consisted of patients with coronary artery disease, DN group consisted of patients with diabetic nephropathy, DNe group consisted of patients with diabetic neuropathy. Spectrophotometry and enzyme-linked immunosorbent assay (ELISA) techniques have been applied for determination of MDA, CAT and SOD respectively. Results: comparing the levels of SOD and CAT in all groups, it was observed that the lowest concentration was in CAD, DN, DNe groups followed by DWC and control groups. Oxidative stress was found increased in CAD, DN, DNe groups as compared to DWC and control groups since, the highest concentration of MDA levels were observed in these groups. A significant inverse correlation was observed of HbA1c, insulin and MDA with SOD, CAT in all diabetic groups. And a significant direct correlation between HbA1C and MDA was also observed in all diabetic groups. Conclusion: The present study confirms susceptibility of diabetic patients to oxidative stress and that poor glycaemic control is associated with free radical-mediated lipid peroxidation. The present study arrived to the conclusion that hyperglycemia and oxidative stress present a high risk for development of diabetic complications and need early intervention.

  1. Hammes HP, Bartmann A, Engel L, W?lfroth P. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40: pp.629-634, 1997.
  2. Cimato AN, Facorro GB, Piehl LL, Sarrasague MMM, Grinspon D, et al. Oxidative damage and antioxidant status in diabetes mellitus and rheumatoid arthritis: A comparative study. Open Clin Chem J 1:pp.92-98, 2008.
  3. MacNee W. Oxidants/antioxidants and COPD. Journal 117 (5_suppl_1): 303S-317S, 2000.
  4. Davari, S.A.Talaei, H.Alaei, and M.Salami,?Probiotics treatment improves diabetes- induced Impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for Microbiome-gut-brain axis,? Neuroscience, vol. 240, pp. 287?296, 2013.
  5. Chelikani, I. Fita, and P. C. Loewen. Diversity of structures and properties among catalases. Cellular and Molecular Life Sciences, vol. 61, no. 2, pp. 192?208, 2004.
  6. Takemoto,M.Tanaka,H.Iwataetal. Low catalase activity in blood is associated with the diabetes caused by alloxan. Clinica Chimica Acta, vol. 407, no.1-2, pp. 43?46, 2009.
  7. Tiedge, S. Lortz, R. Monday, and S. Lenzen. Complementary action of antioxidant enzymes in the protection of bioengineered insulin- producing RINm5F cells against the toxicity of reactive oxygen species.? Diabetes, vol. 47, no. 10, pp. 1578?1585, 1998.
  8. A. Shodehinde and G. Oboh, ?Antioxidant properties of aqueous extracts of unripe Musa paradisiaca on sodium nitroprusside induced lipid peroxidation in rat pancreas in Vitro,? Asian Pacific Journal of Tropical? Biomedicine, vol. 3, no. 6, pp. 449?457, 2013.
  9. Bayens JW, Role of oxidative stress in development of complications in diabetes, Diabetes; 40:pp.405?412, 1991.
  10. Ramesh, R. Karuna, R. S. Sreenivasa et al., ?Effect of Commiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxid ants status in pancreas and heart of streptozotocin induced diabetic rats,? Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 11, pp. 895?900, 2012.
  11. Sharma, B. K. Instrumental Methods of chemical Analysis. 20th ed. Book Code No: CH3-20 / INDIA. Prakashan Media Ltd. P: 45-4, 2001.
  12. Goldstein DE,Little RR,Malone J, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes care; 18:pp.896-909, 1995.
  13. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, pp.351?358, 1979.
  14. Aebi H. Catalase in vitro. Methods Enzymol. 105, pp.121?126, 1984.
  15. Son, S.M. Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes. Diabetes Metab J; 36, pp.190-8, 2012.
  16. Dawud FA, Eze ED, Ardja AA, et al. Ameliorative effects of vitamin C and zinc in alloxan-induced diabetes and oxidative stress in Wistar rats. Curr Res J Biol Sci 4:pp.123e9, 2012.
  17. A. El Boghdady and G. A. Badr, ?Evaluation of oxidative stress markers and vascular risk factorsin patients with diabetic peripheral neuropathy,? Cell Biochemistry and Function, vol. 30, no. 4, pp. 328?334, 2012.
  18. Kimura, F., Hasegawa, G., Obayashi, H., Adachi, T., Hara, H., Ohta, M., Fukui, M., Kitagawa, Y., Park, H., Nakamura, N., Nakano, K., Yoshikawa, T. Serum Extracellular Superoxide Dismutase in Patients with Type 2 Diabetes: Relationship to the development of micro- and macrovascular complications. Diabetes Care., 26, pp.1246-1250, 2003.
  19. Uzel N., Sivas A., Uysal M., Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm. Metab. Respp. 19, pp.89?90, 1987.
  20. Kedziora-Kornatowska K. Z., Luciak M., Blaszczyk J., Pawlak W. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol. Dial. Transplant. 13, pp.2829?2832, 1998.
  21. Aydin A., Orhan H., Sayal A., Ozata M., Sahin G., Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin. Biochem. 34, pp. 65?70, 2001.
  22. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine, 4th ed.; Biosciences Oxford, Oxford University Press Inc.: New York, NY, USA, pp. 127?130, 2007.
  23. Hunt J. V., Smith C. C., Wolff S. P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39, pp.1420?1424, 1990.
  24. Soliman GZA. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetes patients. Singapore J 49:pp.129e36, 2008.
  25. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care; 27(9):21pp.78-83, 2004.
  26. Brownlee, M. The pathological implications of protein glycation. Clin Invest Med 18, pp.275-81, 1995.
  27. Okoduwa SIR, Umar A, Ibrahim S, Bel F. Relationship of oxidative stress 4with type 2 diabetes and hypertension. J Diabetol. 1:1?10, 2013.
  28. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant enzymes and lipid peroxidation in type2 diabetes mellitus with microvascular complications. Open End J.3:13-6, 2009
  29. Lapolla A, Piarulli F, Sartore G, et al. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripher‑ al artery disease. Diabetes Care. 30: pp.670‑676, 2007.
  30. Freitas JP, Filipe PM, Rodrigo FG. Lipid peroxidation in type 2 normolipidemic diabetic patients. Diabetes Res Clin Pract. vol.36,no.2 ,pp.71-5, May 1997. https://doi.org/10.1016/S0168-8227 (97)00032-6
  31. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia.vol.43, no.5, pp.550-7, May2000 https://doi.org/10.1007/s001250051342
  32. Kesavulu, M.M., Rao, B.K. and Giri, R. Lipid peroxidation and antioxidant enzyme status in type 2 diabetes with coronary artery disease. Diabetes Res. Clin. Pract. vol.53, no.1, pp.33-9, 2001.
  33. Sundaram, R.K., Bhaskar, A. and Vijayalingam, S. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Science vol.90, no. 4:pp.255-260, 1996.
  34. Ayodele OE, Alebiosu CO, Salako BL: Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 96:pp.1445 ? 1454, 2004.
  35. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulindependent diabetes: a 1--year follow-up study of 503 patients. Diabet Med 5:pp.126 ? 34, 1987.

[Selma. M Osman. M. Yousif, Mohammed S. M. Abdalla, E. M. A. Elmahdi and Manal. Mohammed. Ramadan. (2018); OXIDATIVE STRESS STATUS IN PATIENTS WITH TYPE2 DIABETES MELLITUS. Int. J. of Adv. Res. 6 (Jun). 455-462] (ISSN 2320-5407). www.journalijar.com

selma mohammed osman mahmoud yousif
Dr.department of biochemistry,Sudan Atomic Energy Commission

DOI:

Article DOI: 10.21474/IJAR01/7231      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7231

Download Full Paper

Download PDF No. of Downloads: 16 | No. of Views: 91